Technically Speakin...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$2.22 -0.09 | -3.90%
06/04/12 - 11:29 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.39 |
| 52 Week High | 4.02 |
| 52 Week Low | 0.34 |
| Avg. Daily Vol. (Mil) | 2.75 |
| Beta (3 year) | 1.69 |
| Share Related Items | |
| Mkt Cap (Mil) | 46.52 |
| Shares Out (Mil) | 121.22 |
| Float (Mil) | 117.99 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 8.10 |
| Current Ratio | 8.20 |
| LT Debt/ Equity | 0.28 |
| Total Debt / Equity | 0.28 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 94.82 |
| Price/Book | 1.23 |
| Price/Cash Flow | -1.00 |
| Per Share Data | |
| Earnings | -0.41 |
| Sales | 0.00 |
| Book Value | 0.31 |
| Cash Flow | -0.37 |
| Business Summary | |
|---|---|
| Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company, focused on developing products for female sexual health, menopause, contraception and male hypogonadism. | |
| General Information | |
| 111 Barclay Boulevard
Suite 280 Lincolnshire, IL 60069 |
|
| www.biosantepharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 54 | |
| CEO: Mr. Stephen M. Simes | |
| Short Interest | |
| Current Month (Mil) | 17.18 |
| Previous Month (Mil) | 17.15 |
| Short Interest Ratio (Days) | 9.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -81.80 |
| Return on Investments | -92.00 |
| Profitability | |
| Gross Margin | 89.80 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with BPAX
- Portfolio NameUser Type
- UserSaveyn walter
- User2012_03
- Userwayne120
- ContributorBreakout Stocks Of The Week...
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
- Contributor3 Small-Cap Stocks on Insid...
- Contributor13 Biotech Stocks Bought an...
- UserSMITTY
- Contributor10 Most Shorted Stocks in B...
Latest BPAX Headlines from TheStreet
- Biosante Stock Gaps Down On Today's Open (BPAX) 06.01.12 | 09:06 am
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Transocean, Netflix, BioSante Are Market Movers 02.27.12 | 05:02 pm
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 02.07.12 | 11:02 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Market Preview: The Year Without a Santa Claus Rally 12.14.11 | 08:12 pm
- Novellus, BioSante: After-Hours Trading 12.14.11 | 07:12 pm
Press Releases for BPAX
- BioSante Pharmaceuticals, Inc. To Present At Jefferies Global Healthcare Conference - Business Wire 06.04.12 | 07:06 am
- BioSante Pharmaceuticals Announces Reverse Stock Split In Order To Maintain NASDAQ Listing - Business Wire 05.31.12 | 08:05 pm
- BioSante Pharmaceuticals Reports First Quarter Financial Results - Business Wire 05.08.12 | 04:05 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - PR Newswire 04.04.12 | 05:04 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.03.12 | 02:04 pm
- BioSante Pharmaceuticals Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of BioSante Pharmaceuticals, Inc. - Business Wire 03.29.12 | 05:03 pm
- BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation - Business Wire 03.20.12 | 07:03 am
- BioSante Pharmaceuticals Reports Financial Results For 2011 And Corporate Highlights - Business Wire 03.13.12 | 05:03 pm
- BioSante Pharmaceuticals, Inc. To Present At Roth Health Care Conference - Business Wire 03.09.12 | 07:03 am
- BioSante’s Prostate Cancer Vaccine Resulted In Stable Disease In Over 50% Of Patients In Newly Published Study - Business Wire 03.05.12 | 07:03 am
Partner Headlines for BPAX
- Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha 03.26.12 | 09:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- What BioSante's Balance Sheet Says About Future R&D - Seeking Alpha 03.01.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
